Equity Markets — Page 3
Page 3 of the Equity Markets archive on FinancialMarkets.com.
Latest articles
- A 1.6-Point Gap Between the Dow and Small Caps Tracked What Each Index Owns
- Computer Prices Are Rising 14 Times as Fast as Core Goods. Chipmakers' Pricing Power Has Become a Rate Problem
- The Steepest AI Losses Wednesday Were at the Borrowers, Not the Chipmakers. CoreWeave Fell Five Times as Far as Nvidia
- IonQ Sold $2 Billion of Stock and Warrants at a 15% Premium. By Afternoon, the Shares Traded 21% Below That Price
- Skydance Stock Shows a 25% Drop. Holders Who Kept Their New Warrants Were Down About 1%
- Washington Wants to Reopen the Permit for a Wind Farm That Is Already Producing Power. Orsted Shares Fell
- AT&T Is Selling AT&T Mexico for $2 Billion. The Unit Earned a Thin Profit Last Year
- SentinelOne Shares Fell 6.4% as It Lined Up $1.25 Billion at Zero Interest
- Liquidia Trades Almost All Its Cash and a Second Market for Peace With United Therapeutics
- A Coaster Death Shut Nine Six Flags Rides, and the Stock Is Heading for Its Weakest Finish Since 2009
- Micron Falls Another 5% as the Chip Selloff Narrows to Memory
- Two Lung-Fibrosis Drugs, One Day, Opposite Results: Syndax Drops Its Program as Bristol's Advances
- Six Flags Shares Fall After Hours as It Closes Nine Coasters Following a Fatal Incident in Georgia
- Service Properties Trust Now Trades Below Where It Was Before a $2 Billion Bid
- Broadcom's CEO Said Two Things About AI. Optical Stocks Fell as Much as 10%
- Korea's Kospi Trips a Trading Curb and Falls 5.5% as Asia's Chip Selloff Spares Hong Kong
- Vicor Opens New ITC Patent Fight Over AI Server Power Systems
- S&P 500 Slips Despite Gains in Nine Sectors as Salesforce Rises on a Double Upgrade
- Lumentum Sheds About $9 Billion as AI Hardware and Memory Stocks Retreat
- Chipotle Falls Below Pre-Rumor Price After Starbucks Rules Out Acquisition
- Bristol Myers Shares Reverse Gains Despite Two Phase 3 Trial Wins
- The Bull Market Turns Four With the S&P 500 Up More Than 110%. The 10-Year Yield Just Hit the Highest Level of the Entire Run.
- BridgeBio Says Real-World Records Favor Its Heart Drug Over Pfizer's. The Study Has the Limits BridgeBio Itself Flagged.
- Tata Motors' "Best and Final" Iveco Offer Cannot Reach Its Lower Threshold Without at Least One of Three Holdout Funds